Description
Antiplatelet and Anticoagulation Therapy In PCI, An Issue of Interventional Cardiology Clinics
The Clinics: Internal Medicine Series
Authors: Angiolillo Dominick J., Price Matthew J.
Language: EnglishSubjects for Antiplatelet and Anticoagulation Therapy In PCI, An...:
65.12 €
In Print (Delivery period: 14 days).
Add to cart the print on demand of Angiolillo Dominick J., Price Matthew J.
Publication date: 03-2017
Support: Print on demand
Support: Print on demand
Description
/li>
This issue of Interventional Cardiology Clinics, edited by Drs. Dominick Angiolillo and Matthew Price, will focus on Antiplatelet and Anticoagulation Therapy in PCI. The topics covered in this volume will span across pretreatment with antiplatelet agents; optimal duration of antiplatelet therapy after PCI; Cangrelor and its role in percutaneous coronary intervention; Ticagrelor and its effects beyond the P2Y12 receptor; dyspnea and Reversibly-binding P2Y12 antagonists; PAR receptor inhibition post-PCI; switching P2Y12 receptor inhibiting therapies; antiplatelet and antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting; antithrombotic therapy to reduce ischemic events in ACS patients undergoing PCI; and the current role of platelet function testing in PCI and CABG, among other topics.
© 2024 LAVOISIER S.A.S.